Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

September 11, 2019 08:00 ET | Source: Daxor Corporation

Daxor Corporation to Exhibit at the 23rd Annual Scientific Meeting of the Heart Failure Society of America

NEW YORK, Sept. 11, 2019 (GLOBE NEWSWIRE) -- Daxor Corporation (NYSE MKT: DXR) an investment company with innovative medical instrumentation and biotechnology operations focused on blood volume...
September 04, 2019 08:00 ET | Source: Daxor Corporation

Daxor Corporation Announces a 38 Percent Rise in BVA-100 Cardiology Kit Sales and Net Gain of $498,111 for Six Months in Filing of Form N-CSR for June 30, 2019

NEW YORK, Sept. 04, 2019 (GLOBE NEWSWIRE) -- Daxor Corporation (NYSE MKT: DXR) an investment company with innovative medical instrumentation and biotechnology operations focused on blood volume...
March 22, 2019 08:30 ET | Source: Daxor Corporation

Daxor Corporation to Exhibit at the Society of Hospital Medicine (SHM) Annual Conference 2019

NEW YORK , March 22, 2019 (GLOBE NEWSWIRE) -- Daxor Corporation (NYSE MKT: DXR) an investment company with innovative medical instrumentation and biotechnology operations focused on blood volume...
September 28, 2018 08:30 ET | Source: Daxor Corporation

Daxor Corporation Appoints Robert J. Michel as Chief Financial Officer

NEW YORK, Sept. 28, 2018 (GLOBE NEWSWIRE) -- Daxor Corporation (NYSE MKT: DXR), an investment company with innovative medical instrumentation and biotechnology operations focused on blood volume...
September 12, 2018 08:30 ET | Source: Daxor Corporation

Daxor Corporation to Exhibit at the 22nd Annual Scientific Meeting of the Heart Failure Society of America

NEW YORK, Sept. 12, 2018 (GLOBE NEWSWIRE) -- Daxor Corporation (NYSE MKT: DXR) an investment company with innovative medical instrumentation and biotechnology operations focused on blood volume...
August 24, 2018 08:30 ET | Source: Daxor Corporation

Daxor Corporation Announces a 23 Percent Rise in BVA-100 Kit Sales in the Area of Cardiology and Filing of Form N-CSR for June 30, 2018

NEW YORK, Aug. 24, 2018 (GLOBE NEWSWIRE) -- Daxor Corporation (NYSE MKT: DXR) an investment company with innovative medical instrumentation and biotechnology operations filed a Form N-CSR...
June 12, 2018 08:30 ET | Source: Daxor Corporation

Daxor Corporation Appoints Kathryn A. Kornafel Vice President of Marketing and Commercial Development

NEW YORK , June 12, 2018 (GLOBE NEWSWIRE) -- Daxor Corporation (NYSE MKT: DXR), an innovative medical instrumentation and biotechnology company focused on blood volume measurement today announces...
May 30, 2018 08:30 ET | Source: Daxor Corporation

Daxor Corporation to Present at the LD Micro 8th Annual Invitational on June 4, 2018

NEW YORK, May 30, 2018 (GLOBE NEWSWIRE) -- Daxor Corporation (NYSE MKT: DXR), an innovative medical instrumentation and biotechnology company focused on blood volume measurement, announced that...
April 19, 2018 09:00 ET | Source: Daxor Corporation

A New Study Published in The Annals of Thoracic Surgery: Daxor’s BVA-100 Device Reveals Unexpected Blood Loss of 38% in Cardiac Surgical Patients Not Detected by Common Test in Use

New York, NY, April 19, 2018 (GLOBE NEWSWIRE) -- Daxor Corporation (NYSE MKT: DXR), an investment company with medical instrumentation and biotechnology operations, announces the publication of new...
March 08, 2018 12:56 ET | Source: Daxor Corporation

Daxor Corporation Announces Rise in Kit Sales, New Device Sale, and Filing of Form N-CSR for 2017 (NYSE MKT LLC: DXR)

New York, NY, March 08, 2018 (GLOBE NEWSWIRE) -- Daxor Corporation, (NYSE MKT: DXR) an investment company with medical instrumentation and biotechnology operations, filed a Form N-CSR disclosing its...

Next Page keyboard_arrow_right